CoImmune, Inc.
PrivateLast Round
Series A
Nov 10, 2020
Total Funding Raised
$56.1M
Company Overview
CoImmune, Inc. is a biotechnology company that specializes in the development of immuno-oncology therapies based on its two proprietary platform technologies, an autologous RNA-loaded dendritic cell technology and an allogeneic CAR-CIK technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CoImmune, Inc. Comparables
Compare CoImmune, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Diakonos Oncology | 82% | |
| CellxLife | 80% | |
| AiVita Biomedical | 74% |
CoImmune, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 10, 2020 | ||||
| Corporate Funding | Feb 13, 2019 |
CoImmune, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| DSC Investment | Series A |
| Korea Investment Partners | Series A |
| SCM Lifescience | Corporate Funding, Series A |
| Brain Asset Management Co.,Ltd. | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 10, 2020
$45M round with SCM Lifescience and Genexine Inc.
- Feb 13, 2019
$11.1M raised from SCM Lifescience and Genexine Inc.
CoImmune, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about CoImmune, Inc.'s valuation, stock price, and market status.
Is CoImmune, Inc. a public or private company?
CoImmune, Inc. is a private company.
What is the current stock price of CoImmune, Inc.?
CoImmune, Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is CoImmune, Inc. worth (valuation)?
Valuation information for CoImmune, Inc. is not publicly available.
Can I buy CoImmune, Inc. stock?
CoImmune, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was CoImmune, Inc.'s last funding round?
CoImmune, Inc.'s most recent funding round was Series A on November 10, 2020.
Who are the main investors in CoImmune, Inc.?
Key investors in CoImmune, Inc. include Korea Investment Partners, Brain Asset Management Co.,Ltd..
Will CoImmune, Inc. IPO soon?
No public IPO plans have been announced for CoImmune, Inc..
How can I track CoImmune, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor CoImmune, Inc.'s secondary market activity and sign up for updates.